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Summary
Artemin (ARTN) is a member of the glial cell line-
derived neurotrophic factor (GDNF) family ligands
(GFLs) which regulate the development and mainte-
nance of many neuronal populations in the mamma-
lian nervous system. Here we report the 1.92 A˚ crystal
structure of the complex formed betweenARTN and its
receptor GFRa3, which is the initiating step in the for-
mation of a ternary signaling complex containing the
shared RET receptor. It represents a new receptor-
ligand interaction mode for the TGF-b superfamily
that reveals both conserved and specificity-determin-
ing anchor points for all GFL2GFRa pairs. In tandem
with the complex structure, cellular studies using re-
ceptor chimeras implicate dyad-symmetric composite
interfaces for recruitment and dimerization of RET,
leading to intracellular signaling. These studies
should facilitate the functional dissection of the spe-
cific versus pleiotropic roles of this system in neuro-
biology, as well as its exploitation for therapeutic
applications.
Introduction
The glial cell line-derived neurotrophic factor (GDNF)
family ligands (GFLs) include GDNF (Lin et al., 1993),
neurturin (NRTN) (Kotzbauer et al., 1996), persephin
(PSPN) (Milbrandt et al., 1998), and artemin (ARTN) (Ba-
loh et al., 1998). GFLs play critical roles in supporting the
development and survival of distinct sets of central and
peripheral neurons (Airaksinen and Saarma, 2002; Baloh
et al., 2000a). The potent neurotrophic activities of GFLs
have stimulated interest in their use as therapeutic
agents for the treatment of neurodegenerative diseases
such as Parkinson’s. GDNF, the founding member in the
family, has shown antiparkinsonian actions in various
animal models and pilot studies with human patients
(Gill et al., 2003; Grondin and Gash, 1998; Slevin et al.,
2005). ARTN has been shown in recent studies to be
effective as a systemic treatment for neuropathic pain
*Correspondence: kcgarcia@stanford.edu(Gardell et al., 2003). Given the importance of GFLs in
basic neurobiology and their potential therapeutic value,
it has become a compelling goal to understand the mo-
lecular basis of the interactions between GFLs and their
receptors.
GFLs belong to the transforming growth factor
b (TGF-b) family because of the conserved seven cyste-
ine residues and structural similarities, but they are dif-
ferent from other members in the signaling pathway
(Saarma, 2000). Unlike other members in the TGF-b fam-
ily (TGF-bs, BMPs, Activins, etc.) which signal through
direct engagement of two different types of serine/
threonine receptor kinases (Massague and Chen,
2000), GFLs exert their activities through the nucleation
of a ternary complex containing a nonsignaling, ligand-
specific GFRa receptor and a signaling and shared tyro-
sine kinase receptor RET (Durbec et al., 1996; Treanor
et al., 1996; Trupp et al., 1996; Worby et al., 1996). One
widely accepted model is that GFL first binds its prefer-
ential GFRa receptor. This binary complex, then, recruits
RET through the formation of a composite GFL/GFRa in-
terface, which triggers the activation of the intracellular
tyrosine kinase domain (Airaksinen et al., 1999). The
GFRa receptors contain three cysteine-rich repeats
that appear to mark distinct extracellular domains (D1,
D2, and D3). Four different GFRa receptors (GFRa1-4)
have been identified (Baloh et al., 1998; Buj-Bello
et al., 1997; Enokido et al., 1998; Jing et al., 1996), and
it is now established that GFRa1 binds preferentially to
GDNF, GFRa2 to NRTN, GFRa3 to ARTN, and GFRa4
to PSPN (Airaksinen et al., 1999).
The protein fold of GDNF is a canonical ‘‘cystine-knot’’
motif, formed by a hallmark pattern of seven cysteine
residues within the primary sequence, and one inter-
chain disulfide bond linking two GDNF monomers to
form a homodimer (Eigenbrot and Gerber, 1997; Sun
and Davies, 1995). The structure of a single unliganded
domain corresponding to the third cysteine-rich repeat
(D3) of GFRa1 has been reported, which did not posses
ligand binding activity, but from which the GDNF inter-
actions were modeled (Leppanen et al., 2004). In order
to begin to elucidate the molecular basis of GFL recep-
tor recognition and activation, we report here the crystal
structure of ARTN bound to the ligand binding domains
of GFRa3, together with cellular studies that collectively
point to a convergent binding and activation mode be-
tween GFL and their receptors across this important
neurotrophic factor family.
Results
Biochemical Studies and Structure Determination
A soluble ectodomain of human GFRa3 (D1D2D3) (resi-
dues 32–363) with a C-terminal hexa-histidine tag, and
human ARTN (residues 139–237) without His-tag were
coexpressed in insect cells. Gel filtration chromatogra-
phy of the Nickel-agarose captured material resolved
a major peak consisting of the ARTN2GFRa3 complex,
followed by excess GFRa3 (Figure 1A). The molecular
weight of the ARTN2GFRa3 complex determined by
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(A) Gel filtration analysis of the ARTN2GFRa3 (D1D2D3) complex. ARTN without hexa-histidine tag copurifies with GFRa3 molecules containing
hexa-histidine tag.
(B) Measurement of the molecular weight of the ARTN2GFRa3 (D1D2D3) complex by multiangle laser light scattering (MALS). The measured
98.5 kDa molecular weight is consistent with the 1:2 stoichiometry in the ARTN2GFRa3 complex (calculated MW = 97.2 kDa).
(C) Isothermal titration calorimetry (ITC) of GFRa3 receptor with ARTN. The N value of 0.63 indicates a 1:2 stoichiometry of one ARTN dimer bind-
ing to two GFRa3 monomers. The theoretically correct value of N = 0.5 is in practice difficult to obtain due to the slight imprecision in protein
concentration measurements using different methods. The affinity value of Kd = 90 nM compares to the affinity of ARTN for GFRa3 measured
on cells giving a Kd = 1-10 nM. The lower affinity is what is commonly observed when receptor affinities are measured with soluble molecules
in a free solution state compared to the receptors being constrained to the cell surface. In the solution state, there is a rigid body entropy penalty
(rotation and translation) that results in a reduction in the observed binding free energy.
(D) A representative electron density map (SIGMAA 2Fo-Fc, 1.2s) around residues Trp 205 and Met 199 in the ARTN/GFRa3 binding interface.
Several water molecules mediate hydrogen bonds at the perimeter of the interface, but there are no buried waters within the tightly packed core.multiangle laser light scattering (MALS) is 98.5 kDa
(Figure 1B), indicating the complex consists of two re-
ceptor molecules and one ARTN homodimer. The 1:2
stoichiometry was further validated by isothermal titra-
tion calorimetry (Figure 1C), which indicated that the
complex is composed of one ARTN homodimer and
two GFRa3 (D1D2D3) receptors.
During crystallization, the GFRa3 N-terminal domain
(D1) was spontaneously proteolyzed by remaining trace
quantities of proteases after purification. This digestion
resulted in the formation of crystals containing a com-
plex consisting of the GFRa3 D2D3 domains (residues
146–363) and one ARTN homodimer, which was con-
firmed by N-terminal sequencing of washed crystals.That D1 is dispensable for ARTN2GFRa3 complex for-
mation is consistent with previous findings that GFRa4
as well as some isoforms of GFRa2 do not contain
a D1, indicating it is not required for GFL binding or re-
cruitment of RET (Airaksinen et al., 1999; Scott and Iba-
nez, 2001). A combination of heavy atom phasing and
molecular replacement methods were used to determine
the complex structure at 1.92 A˚ resolution, as well as two
different unbound ARTN structures at resolutions of
1.76 A˚ and 2.6 A˚, respectively (Figure 1D and Table 1).
Overall Structure of the ARTN-GFRa3 Complex
The complex consists of a single ARTN homodimer
together with two GFRa3 D2D3 molecules in a 1:2
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GFRa3-ARTN complex ARTN (form 1) ARTN (form 2) ARTN derivative (Hg)
Data collectiona
Space group P21 P6522 P65 P65
Cell dimensions
a, b, c (A˚) 73.7, 41.5, 119.9 47.9, 47.9, 190.1 94.2, 94.2, 219.2 94.4, 94.4, 219.5
a, b, g (º) 90, 103.6, 90 90, 90, 120 90, 90, 120 90, 90, 120
Resolution (A˚) 40.0-1.92 40.0-1.76 40.0-2.60 40.0-2.80
Rmerge 8.1 (51.5) 7.4 (54.8) 8.8 (59.4) 6.6 (33.3)
I / sI 21.0 (3.0) 42.5 (2.4) 24.2 (2.9) 20.7 (3.0)
Completeness (%) 98.9 (98.5) 89.4 (96.4) 99.8 (100) 99.3 (97.1)
Redundancy 11.8 21.2 18.0 9.2
Refinement
Resolution (A˚) 50.0-1.92 50-1.76 50-2.6
No. reflections 54357 13670 33810
Rwork / Rfree 21.9/26.6 23.9/25.5 30.8/35.3
No. atoms
Protein 4574 736 4416
Water 236 113
Carbohydrate 61
B-factors
Protein 37.3 38.1 43.9
Water 39.2 41.3
Carbohydrate 42.4
Rms deviations
Bond lengths (A˚) 0.021 0.016 0.04
Bond angles (º) 1.82 1.78 3.24
a Number in the parentheses are statistics for the highest resolution shell.stoichiometry (Figures 2A and 2B). One symmetric
ARTN dimer binds two GFRa3 molecules at each of its
two distal tips, resulting in the complex spanning
w130 A˚ in the dimension parallel to the cell membrane
(Figure 2A). The noncrystallographic 2-fold related
halves of the complex are highly similar to each other
(Figure 2B), being related by a rotation of w179º and
with a root-mean-square difference (rmsd) of w0.6 A˚
for 298 Ca positions.
ARTN Homodimer
ARTN is a homodimer in which the two monomers are
assembled in a ‘‘tail-to-head’’ fashion, linked by an inter-
chain disulfide bond (Figures 2A and 2B). The ARTN
monomer structure is composed of two b sheet fingers,
a cystine-knot core motif, and an a-helical heel region.
The finger 1 is composed of two long continuous anti-
parallel b strands, and finger 2 has interruptions in the
middle, resulting in five relatively short b strands in the
b sheet. In the dimer, the helix in the heel region of one
ARTN monomer contacts the finger region of another
monomer with its helical axis nearly perpendicular to
the b strands (Figures 2A and 2B). The structure of
ARTN bound to GFRa3 is very similar to the two un-
bound structures, as reflected in the rmsd of w1 A˚
for Ca superimposition in both monomer and dimer
levels. Structural comparison of ARTN with GDNF
shows an approximate 20º difference in the angle be-
tween the finger and heel regions, which results in
poor monomer superimposition (w7 A˚ rmsd) and dif-
ferent homodimer orientations (Figures S1B and S1C;
see the Supplemental Data available with this article
online).GFRa3 ‘‘D2D3’’ Module
The compact globular structure of the GFRa3 D2D3
fragment was unexpected based on speculation that
the GFRa fold into three independent domains (Leppa-
nen et al., 2004). Instead, the ‘‘D2D3’’ modules are
closely packed together, with each cysteine-rich repeat
domain contributing five a helices (a1–a5 for D2, a6–a10
for D3) that then stack in two roughly triangular spirals
(Figure 2C). The interface between the two domains
forms a large hydrophobic core between the outermost
helices (a3 and a4) of the D2 domain with the innermost
helices (a8, a10 and a8-a9 linker) of the D3 domain, re-
spectively. The residues involved in the hydrophobic
interactions include Leu200, Phe204, Leu216, Leu217,
Leu289, Tyr292, Leu293, Ile296, Phe304, and Ile345,
which are highly conserved in all GFRa receptors. The
disulfide-bond pattern is very similar in both D2 and
D3, which has five disulfide bonds distributed at the
three corners of the triangular spiral to fix the scaffold
(Figure 2C). There are no disulfide bonds in the interface
between D2 and D3. Considering that all cysteine resi-
dues in the disulfide-bonds are conserved across the
GFRa family and the correspondence of GFRa3 D3 to
the isolated GFRa1 D3 domain previously solved (rmsd
ofw0.6 A˚ for 62 Ca atoms in the helical region) (Leppa-
nen et al., 2004) (Figure S1A; see the Supplemental Data
available with this article online), we believe that other
GFRa receptors will have similar architectures.
Overview of the ARTN/GFRa3 Binding Interface
The interaction of ARTN with GFRa3 occurs through the
protruding tips of fingers 1 and 2 in ARTN inserting into
a pocket in the center of a triangle of a helices in the D2
domain of GFRa3 (Figure 3A). The D3 domain has no
Structure
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In (A), the view is approximately parallel to where a cell membrane would lie underneath the complex, in (B) the view is from above, looking down
on the complex with membrane underneath (approximately a 90º rotation of the complex in (A) toward the reader. One ARTN dimer (monomers
in cyan and green) binds two GFRa3 receptors. The observed N-linked carbohydrates at Asn309 position of GFRa3 are shown as sticks in
dark blue.
(C) The stacked D2 and D3 subdomains in the GFRa3 receptor ‘‘D2D3’’ module. The D2 is shown in deep salmon color, while the D3 is shown in
red. Disulfide bonds are shown in yellow. The program PyMol (DeLano, 2002) was used to make all the following figures.interaction with ARTN. The role of the D3 domain ap-
pears to be to stabilize the D2 domain, in contrast to
speculation that it forms direct ligand contacts (Leppa-
nen et al., 2004). As a result of complex formation, 16
residues from ARTN and 19 residues from GFRa3 bury
a total of w1500 A˚2 surface (Figures 3C and 3D; also
see Table S1 in the Supplemental Data available withthis article online). The interface between ARTN and
GFRa3 can be described as a small hydrophobic core
surrounded by a much larger halo of charged and hydro-
philic interactions (Figures 3C and 3D), consistent with
our thermodynamic measurements indicating that bind-
ing is enthalpy driven, which is usually a signature for
polar and charged interactions (Figure 1C) (Carneiro
Structure of a GDNF Family Receptor-Ligand Complex
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(A) Molecular surfaces highlight the knob-in-hole complementarity between the protruding ARTN finger region (cyan) and the recessed center of
a triangular spiral of a helices in GFRa3 D2 (deep salmon) formed by helices a1, a2, and a5.
(B) Interatomic contacts between ARTN and GFRa3, with the hydrophobic core of ARTN surrounded by a halo of polar interactions.
(C) Electrostatic footprints and complementarity of buried residues of ARTN on top of the GFRa3 surface.
(D) Electrostatic footprints and complementarity of buried residues of GFRa3 on top of the ARTN surface.et al., 2002; He et al., 2001). Both apolar and polar seg-
ments in ARTN/GFRa3 contact interface contain con-
served residues in GFLs and GFRa receptors. These
conserved residues clearly serve as the common anchor
points in all GFL2GFRa pairs, which are then sur-
rounded by specificity determinants unique to each
GFL2GFRa pair.
Conserved Hydrophobic and Hydrophilic
Interactions
The protruding hydrophobic core at the ARTN fingertips,
composed of Trp205 and Met199 (Figure 3B), is highly
conserved in other GFLs (Figures 4A and 4B). It is struc-
turally and chemically matched on the complementary
GFRa3 surface formed by a recessed ring of exposing
residues including Arg179, Tyr182, Gly183, Arg230,
and Ala236 (Figure 4B). The main contact hydrophobic
residue Tyr182 in GFRa3 is strictly conserved, and hy-
drophobic positions Gly183 and Ala236 are also re-
placed by hydrophobic residues in other GFRa recep-
tors (Figure 4C). Upon complex formation, Trp205 and
Met199 from ARTN undergo large sidechain movements
and buryw28% of the total surface area in the interface(Figure 3C; also see Figure S1D in the Supplemental
Data available with this article online). Underscoring
the importance of Trp205 and Met199 positions, their
mutations in GDNF result in a complete loss of binding
activity for GFRa1 (Eketjall et al., 1999).
The majority of the ARTN/GFRa3 interface is formed
by several patches of matching complementary charge
(Figures 3C and 3D). The conserved hydrophilic patch
involves salt bridges between residue Glu143 from
ARTN and residues Arg179 and Arg230 in GFRa3
(Figure 3B), which are strictly conserved in all GFRa re-
ceptors (Figure 4C). Glu143 is also strictly conserved
in all GFLs (Figure 4A) and is one of the most important
binding determinants for the interactions between
GDNF and GFRa1 (Eketjall et al., 1999). We therefore
speculate that these two binding epitopes, one hydro-
phobic and one charged, constitute ‘‘anchor’’ points
for GFLs interactions with their GFRa receptors.
GFL-GFRa Specificity Determinants
We also find three epitopes in the ARTN-GFRa3 com-
plex that are potential determinants of specificity be-
tween GFLs and their preferential GFRa receptors. The
Structure
1088Figure 4. Conservation of Shared and Spe-
cific Ligand-Receptor Anchor Points across
the GDNF Family Ligands and Receptors
(A) Sequence alignment of GFL around the
region of receptor contact. The more con-
served positions are colored in blue, while
the more variable ligand-specific residues
are colored in green to correspond with the
coloring of the ‘‘open-book’’ surface repre-
sentation, shown in panel (B) of the ARTN/
GFRa3 interface.
(B) Common binding residues are colored in
blue, and ligand-receptor specific residues
are colored green on a background of the to-
tal buried surface (gray). ARTN is in the left
panel and GFRa3 in the right panel.
(C) Sequence alignment of GDNF a receptors
(GFRa) around the region of ligand contact.
As for (A), the conserved positions are col-
ored in blue, while the variable ligand-specific
residues are colored in green.first is a van der Waals interaction between positions
Ala195 (ARTN) and Glu184 (GFRa3) (Figure 3B). The
other three GFLs, GDNF, NRTN, and PSPN, have nega-
tively charged residues (Asp or Glu) at position 195
(Figure 4A), and we expect that the repulsion from
Asp-Glu or Glu-Glu would not favor the binding of
GDNF, NRTN, and PSPN with GFRa3. Their preferential
receptors GFRa1, GFRa2, and GFRa4 have small neutral
residues at position 184 instead of a negatively charged
residue (Figure 4C). A patch of complementary charge
between Arg146 of ARTN and Asp176 of GFRa3 is
another potential specificity determinant (Figure 3B).
Receptors GFRa1 and GFRa2 both have Lys instead of
Asp at position 176 (Figure 4C), which would result in
repulsion by an Arg-Lys interaction in a mismatched
ligand-receptor pair. The last potential determinant is
a hydrophobic contact between Leu144 of ARTN andMet167 in GFRa3 (Figure 3B). The corresponding resi-
dues found at position 144 in GDNF, NRTN, and PSPN
are Glu, Thr, and Lys, respectively, that match with
Lys, Lys, and Glu, respectively, at position 167 in
GFRa1, GFRa2, and GFRa4 (Figures 4A and 4C). These
charge reversals would then be repulsive in mismatched
complexes (GDNF-GFRa4, PSPN-GFRa1, and PSPN-
GFRa2).
To probe the importance of the D2D3 region of GFRa3
for interaction with artemin as well as RET, we generated
mutant chimeric receptors between GFRa2 and GFRa3
and directly test their ability to form functional ternary
receptor signaling complexes in response to NRTN
and ARTN, respectively (Figure 5). The experiment was
done by transiently transfecting the chimeric receptor
together with Gal4-Elk1/Gal4-luciferase reporter system
into fibroblasts that stably express RET. This system,Figure 5. Functional Demonstration that Re-
ceptor Specificity for GFL Is Dictated by the
D2 Domain
Substitution of GFRa3 D2 domain with that of
GFRa2 results in conversion to NRTN speci-
ficity, while substitution of GFRa2 D2 domain
with that of GFRa3 results in conversion to
ARTN specificity. NIH-3T3 fibroblasts stably
expressing human RET were transfected
with the indicated construct, together with
the Gal4-Elk1 fusion and a Gal4-luciferase
reporter. Cells were deprived of serum, and
stimulated with 50 ng/mL of the indicated li-
gand for 6 hr. Experiments were done in trip-
licate, and normalized to the response to the
preferred ligand (ARTN for GFRa3, and NRTN
for GFRa2). The residues in bold below corre-
spond to the region conferring ligand speci-
ficity.
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ing Modes in the TGF-b Superfamily
Each of the complexes are shown in approx-
imately similar orientations with respect to
the ligand, and the cell membrane would lie
underneath the complexes. (A) Artemin
bound to GFRa3; (B) TGF-b3 bound to TbRII;
(C) BMP-7 bound to ActRII ; (D) Activin bound
to ActRIIB; (E) BMP-2 bound to ActRII and
BMPR-1A.which utilizes the ability of the Gal4-Elk1 fusion protein
to respond to MAP kinase activity and activate tran-
scription of the Gal4-luciferase reporter, has been
used previously to monitor NGF-TrkA activation of
MAP kinase in PC12 cells and GDNF-RET activation of
MAP kinase in neuroblastoma cell lines (Worby et al.,
1996; York et al., 1998). As expected, wild-type GFRa2
responded only to NRTN, and GFRa3 only to ARTN. A
chimeric GFRa containing N-terminal GFRa2 (Ser22 to
His160) together with C-terminal GFRa3 (Cys162 to
Asn374) responded only to ARTN. In contrast, a chimera
containing N-terminal GFRa2 (Ser22 to Ser213) with
C-terminal GFRa3 (Pro210 to Asn374) responded only
to NRTN, indicating that residues involved in ligand
specificity lie between Cys162 and Glu209, in the D2 re-
gion of GFRa3. Confirming this, an additional chimera
with N-terminal GFRa3 (Gly31 to Pro157) fused with
C-terminal GFRa2 (Glu214 to Gln374), in which the D2
region was derived from GFRa2, maintained respon-
siveness only to NRTN. Therefore, these functional re-
ceptor studies indicate that the ligand specificity is dic-
tated by the stretch of residues from Cys162 to Glu209,
which is the major region of GFRa3 contacting ARTN in
our structure.
Discussion
The activated receptor complexes of GFLs consist of
the shared signaling tyrosine kinase receptor RET and li-
gand-specific nonsignaling GFRa coreceptors (Airaksi-
nen and Saarma, 2002). This receptor composition is
unique in the TGF-b superfamily, because other mem-
bers, such as BMPs, Activins, and TGF-bs, have two
different types of serine/theronine receptor kinases
(Massague and Chen, 2000). Previous studies have re-
vealed the complex structures of BMPs, Activins, andTGF-bs with their receptors, which all have one single
b sheet fold in the receptor ectodomain (Figures 6B–
6E) (Allendorph et al., 2006; Greenwald et al., 2003;
Greenwald et al., 2004; Hart et al., 2002; Kirsch et al.,
2000; Thompson et al., 2003). Our ARTN2GFRa3 com-
plex structure adds a new ligand-receptor binding
mode in the TGF-b superfamily because the GFRa3
ectodomain has multiple domains mainly composed of
a helices. Although still substantially different, the over-
all docking mode of ARTN with GFRa3 is most similar to
that seen in the TGF-b32TbRII complex (Figures 6A and
6B) (Hart et al., 2002), which also uses the ligand finger-
tips to engage receptor. Structural comparison of the li-
gand-receptor complexes in the TGF-b superfamily also
shows different intermonomer angles in the homodi-
meric ligands (Figures 6A–6E). Such homodimeric struc-
tural flexibility has been proposed to be a potential
mechanism of receptor signaling modulation (Green-
wald et al., 2004; Thompson et al., 2003). Variable homo-
dimer orientations have also been observed between
ARTN and GDNF (Figure S1C; see the Supplemental
Data available with this article online), and we propose
that it would result in different relative orientations of
two RET molecules in the ternary signaling complex,
potentially influencing the activation of its intracellular
kinase domains.
GFL must engage GFRa in order to recruit the shared
tyrosine kinase receptor RET (Airaksinen and Saarma,
2002), suggesting that RET recognizes a composite sur-
face formed by the conjunction of GFL and GFRa recep-
tor (Scott and Ibanez, 2001; Trupp et al., 1998). Alterna-
tively, ligand capture by GFRa on the membrane may
increase the effective concentration of GFL at the cell
surface for presentation to RET through a noncomposite
RET binding surface on GFL, or the GFL binding will in-
duce the conformational changes of the noncomposite
Structure
1090Figure 7. Putative RET Binding Surface on
the Artemin2GFRa3 Complex
The 2-fold related potential RET binding sites
are circled in dotted lines. Colored and la-
beled residues are conserved in GFRa recep-
tors and surface-exposed in the GFRa3
structure. The magenta patch in ARTN are
the corresponding regions found in GDNF to
be important for RET activation.RET binding surface on GFRa. The RET binding region of
GFRa1 has been delimited to a region analogous to the
GFRa3 ‘‘D2D3’’ module described here (Scott and
Ibanez, 2001). Given the shared usage of RET by all
GFL2GFRa complexes, the RET binding surface on
GFRa may be conserved. We found 12 conserved
GFRa residues that map onto an exposed face, involving
both D2 and D3, on one side of GFRa3 in the complex,
thereby defining a potential RET binding site (Figure 7).
Most of these conserved residues are charged, which
is consistent with homolog-scanning mutagenesis of
RET, indicating that charged residues in the first cad-
herin-like domain of RET are important for formation of
GDNF2GFRa12RET complex (Kjaer and Ibanez,
2003). We propose that this face of GFRa3 forms part
of the RET binding surface and includes residues from
helices a2, a3, a7, a8, a9, and a10. This RET binding sur-
face would be located adjacent to the two bottom fin-
gers in ARTN (magenta highlighted in Figure 7), which
could form part of the composite RET interaction sur-
face. These ARTN residues do not interact with
GFRa3; however, they are located within a region previ-
ously shown using GFL homolog scanning mutagenesis
to be essential for RET activation (Baloh et al., 2000b).
Although there are several conserved residues on the
opposite face of GFRa3, it is less likely to serve as the
RET binding surface due to the presence of a bulky
Asparagine (309)-linked glycan prominently in the mid-
dle of the region of possible interaction (Figure 7). The
two potential RET binding surfaces we proposed here
are related by the intrinsic 2-fold symmetry and also an-
gled toward one another in roughly a V-shape, such that
two RET molecules, if bound along the approximate
long axis of the GFRa, would be steered into closer
apposition as it enters the cell membrane, resulting in re-
duced proximity of their intracellular kinase domains.
Experimental Procedures
Protein Preparation
Proteins used in this study were expressed using the Baculovirus
system (Pharmingen) in insect cells. Briefly, insect Spodoptera fru-
giperda (Sf9) cells were used for generating high titer recombinant
virus and were cultured at 28ºC using SF900 II SFM medium (Invitro-
gen). Trichopulsia ni (High-Five) cells (Invitrogen) were used to ex-
press the recombinant protein and were grown in Insect Xpress
medium (Cambrex) at 28ºC. Human GFRa3 ectodomain (residues
Asp322Pro363) with C-terminal hexa-histidine and the N-terminal
truncated human ARTN (Gly1392Gly237) were cloned into the
pAcgp67A vector (Pharmingen). The ARTN2GFRa3 complexeswere obtained by coexpression in High-Five cells and purified by
Ni-NTA, FPLC Superdex 200 size exclusion, and Mono S ion-ex-
change columns (Pharmacia). Unbound ARTN was also expressed
in High-Five cells and purified by Ni-NTA and Superdex 200 size
exclusion column.
Crystallization and Data Collection
Crystals of ARTN2GFRa3 complex were grown by hanging-drop va-
por diffusion at 20ºC. The well solution contained 0.1 M Imidazole
(pH 8.0), 20% (v/v) ethanol, and 0.1 M MgCl2. The crystals grew to
a maximum size of 0.2 3 0.1 3 0.05 mm3 over the course of 15220
days. The crystals belong to the P21 space group and contain one
full complex per asymmetric unit. Two different forms of ARTN crys-
tals (spacegroup P6522 and P65, respectively) were obtained at 20ºC
with hanging-drop vapor diffusion method. One was grown with the
well solution of 0.1 M Hepes (pH 7.5), 12%–16% (w/v) PEG3350, and
0.1 M MgCl2, the other one with the well solution of 0.1 M Bis-Tris
propane (pH 7.0) and 3 M NaNO3. All data were collected at
Advanced Light Source (UC Berkeley) and Stanford Synchrotron
Radiation Laboratory. The data sets were collected at 100 K and pro-
cessed using HKL2000 software suite (Otwinowski and Minor, 1997).
More statistics of crystal and data collection are in Table 1.
Structure Determination and Refinement
The structure of unbound ARTN was first determined by single iso-
morphous replacement with anomalous scattering (SIRAS) method
with a mercury derivative in P65 form, which has three dimers in
the asymmetric unit. The derivative was prepared by soaking a single
crystal in the mother liquor containing 100 mM Thimerosal for 1 hr.
The heavy atom binding sites were determined with SHELXD
(Schneider and Sheldrick, 2002). The initial phases were calculated
in SHARP (de la Fortrelle and Bricogne, 1997) and improved with
SOLOMON (Abrahams and Leslie, 1996). The ARTN model from
P65 form was used to determine its structure in P6522 form (one
monomer per asymmetric unit) with PHASER (Read, 2001). The
structure of the ARTN2GFRa3 complex was determined by the mo-
lecular replacement method with our ARTN and GFRa1 D3 domain
structures (PDB ID: 1Q8D) as the search models. Program PHASER
(Read, 2001) was used to locate the positions of one ARTN dimer
and two GFRa3 D3 domains in the complex. After density improve-
ment with ARP/wARP (Perrakis et al., 1999), the residues in the D2
domain were built into the map by using COOT (Emsley and Cowtan,
2004). All structures were refined with CNS (Brunger et al., 1998) and
REFMAC (CCP4 package) (Murshudov et al., 1997). Structure deter-
mination and refinement statistics are listed in Table 1.
Isothermal Titration Calorimetry (ITC) and Multiangle Light
Scattering (MALS)
Calorimetry titrations were carried out on the VP-ITC calorimeter
(MicroCal) at 20ºC, with 15 mM GFRa3 titrated against 2.5 mM
ARTN dimer. Both GFRa3 and ARTN were prepared in a buffer con-
taining 0.01 M Hepes (pH 7.2) and 0.5 M NaCl. The data were pro-
cessed with the MicroCal Origin 7.0 software. A DAWN EOS (Waytt
Technology) equipped with a K5 flow cell and a 30 mW linearly po-
larized GaAs laser of wavelength 690 nm was used in MALS exper-
iment. Data analysis was carried out real time using ASTRA (Wyatt
Structure of a GDNF Family Receptor-Ligand Complex
1091Technologies) and molecular weight was calculated using the Debye
fit method.
Receptor Activation Assays
They were performed as described previously (Baloh et al., 2000b).
Briefly, 3T3 fibroblasts stably expressing human RET were plated
at 85,000 cells/well in 12-well plates and transfected using Superfect
(Qiagen) with the reporter plasmids (250 ng/well Gal4-Luc, 50 ng/
well Gal4-Elk), CMV-lacZ (50 ng/well) for transfection normalization,
a CMV-GFRa (500 ng/well) expression plasmid, and 650 ng/well
pBluescript as a carrier for a total of 1.5 mg of DNA/well. Cells were
switched to 0.5% serum-containing medium the morning after
transfection, stimulated for 6 hr with 50 ng ml21 of recombinant
artemin or neurturin, and harvested 36 hr after transfection. The
average luciferase activity of triplicate samples was normalized to
b-galactosidase activity of the cotransfected lacZ reporter to control
for transfection efficiency.
Supplemental Data
Supplemental data including a supplemental figure and table are
available at http://www.structure.org/cgi/content/full/14/6/1083/
DC1/.
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